DeNovaMed Inc.
PrivateLast Round
Seed
Aug 8, 2012
Total Funding Raised
$1.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DeNovaMed Inc. operates in Healthcare & Life Sciences and is based in Halifax. Its latest recorded funding round was a Seed round in August 2012.
DeNovaMed Inc. is a biotechnology company that develops novel antibiotic therapies to combat drug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeNovaMed Inc. Comparables
Compare DeNovaMed Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sequella, Inc. | 80% | |
| Deinove | 78% | |
| Microbion Corporation | 77% |
For institutional investors. Book with your work email.
DeNovaMed Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 8, 2012 | ||||
| Grant | Apr 1, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DeNovaMed Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Grant |
| Innovacorp | Seed |
| Canada Foundation for Innovation | Grant |
| National Research Council of Canada | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 30% MoM.
- Jul 27, 2026
Monthly visitors grew 126% MoM.
For institutional investors. Book with your work email.
DeNovaMed Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DeNovaMed Inc.'s valuation, stock price, and market status.
Is DeNovaMed Inc. a public or private company?
DeNovaMed Inc. is a private company.
What is the current stock price of DeNovaMed Inc.?
DeNovaMed Inc. is a private company, so its shares have no public market price. Caplight tracks DeNovaMed Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DeNovaMed Inc. worth (valuation)?
Valuation information for DeNovaMed Inc. is not publicly available.
Can I buy DeNovaMed Inc. stock?
DeNovaMed Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DeNovaMed Inc.'s last funding round?
DeNovaMed Inc.'s most recent funding round was Seed on August 8, 2012.
Who are the main investors in DeNovaMed Inc.?
Key investors in DeNovaMed Inc. include Innovacorp.
Will DeNovaMed Inc. IPO soon?
No public IPO plans have been announced for DeNovaMed Inc..
How can I track DeNovaMed Inc. secondary market activity?
Caplight tracks bids, offers, and trades in DeNovaMed Inc.'s shares on secondary markets.